Cervical cancer risk in HPV‐positive women after a negative FAM19A4/mir124‐2 methylation test: A post hoc analysis in the POBASCAM trial with 14 year follow‐up

DNA methylation analysis of cervical scrapes using FAM19A4 and mir124‐2 genes has shown a good clinical performance in detecting cervical cancer and advanced CIN lesions in need of treatment in HPV‐positive women. To date, longitudinal data on the cancer risk of methylation test‐negative women are l...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Izdano u:Int J Cancer
Glavni autori: De Strooper, Lise M.A., Berkhof, Johannes, Steenbergen, Renske D.M., Lissenberg‐Witte, Birgit I., Snijders, Peter J.F., Meijer, Chris J.L.M., Heideman, Daniëlle A.M.
Format: Artigo
Jezik:Inglês
Izdano: John Wiley and Sons Inc. 2018
Teme:
Cancer Therapy and Prevention
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC6099282/
https://ncbi.nlm.nih.gov/pubmed/29663363
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/ijc.31539
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items